Journal of Drug Metabolism & Toxicology

Journal of Drug Metabolism & Toxicology
Open Access

ISSN: 2157-7609

+32-466-901905

Aims and Scope

Journal of Drug Metabolism & Toxicology (JDMT) is a broad-based journal founded on two key tenets: To publish the most exciting researches related to Drug Metabolism & Toxicology: Second to provide  a rapid turn-around time possible for reviewing and publishing of articles freely for research, teaching and reference purposes.

It is basically aimed at the Clinical Practitioners, medical/ health practitioners, students, professionals and researchers and professional bodies and institutions. All works published by Longdom Publishing are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited.

Journal of Drug Metabolism & Toxicology (JDMT) strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref.  Journal of Drug Metabolism & Toxicology (JDMT) will keep up-to- date with latest advances in the field of Drug Metabolism & Toxicology. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Journal of Drug Metabolism & Toxicology (JDMT) are freely accessible to everyone immediately after publication. Journal of Drug Metabolism & Toxicology (JDMT) supports the Bethesda Statement on Open Access Publishing.

Londom Publishing Group is ardent to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in Longdom scientific and technical disciplines

All published articles will be assigned DOI provided by CrossRef. Journal of Drug Metabolism & Toxicology will keep upto date with latest advances in the field and papers published in Journal of Drug Metabolism & Toxicology will reach the readers directly by email for free of cost

Distributed widely through the Internet.

Archived online in the transactions of the Longdom Publishing, which provides the international scientific community with immediate and permanent access to individual papers

Journal of Drug Metabolism & Toxicology accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in Longdom field.

Open Access is a publication model, that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. Drug Metabolism & Toxicology strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Drug Metabolism & Toxicology are freely accessible to everyone immediately after publication

All works published by Longdom Publishing are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Drug Metabolism & Toxicology supports the Bethesda Statement on Open Access Publishing.

Definition of Open Access Publication

An Open Access Publication is one that meets the following two conditions:

  • The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
     
  • A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).

As a member of Publisher International linking Association, PILA, Journal of Drug Metabolism & Toxicology (of Londom Publishing Group) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.

Note:

Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.

Top